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Background: The objective of this study was to evaluate the effects of herbal medicines, such as Radix Dipsaci
(RDD), Pyrola Herb (PHD), and Cynomorium songaricum decoction (CSD), on osteoporotic rats induced by
ovariectomy (OVX).
Methods: OVX or sham operations were performed on 69 virgin Wistar rats that were divided into six groups: sham
(sham, n = 12), OVX control group (OVX, n = 12), and OVX rats with treatments (diethylstilbestrol, E2, n = 12; RDD,
n = 11, PHD, n = 11, and CSD, n = 11). Non-surgical rats served as normal control (NC, n = 12). The treatments began
four weeks after surgery and lasted for 12 weeks. Bone mass and bone turnover were analyzed by
histomorphometry. Levels of protein expression and mRNA of OPG and RANKL in osteoblasts (OB) and bone
marrow stromal cells (bMSC) were evaluated by immunohistochemistry and in situ hybridization.
Results: Compared to NC and sham rats, trabecular bone formation was significantly reduced in OVX rats, but
restored in E2-treated rats. Treatment with either RDD or PHD enhanced trabecular bone formation remarkably. No
significant change of bone formation was observed in CSD-treated rats. OPG expression of protein and mRNA was
reduced significantly in OB and bMSC of OVX control rats. RANKL expression of protein and mRNA was increased
significantly in OB and bMSC of OVX control rats. These effects were substantially reversed (increased in OPG and
decreased in RANKL) by treatment with E2, RDD, or PHD in OB and bMSC of OVX rats. No significant changes in
either OPG or RANKL expression were observed in OB and bMSC of OVX rats treated with CSD.
Conclusions: Our study showed that RDD and PHD increased bone formation by stimulating overexpression of
OPG and downregulation of RANKL in OB and bMSC. This suggests that RDD and PHD may be used as alternative
therapeutic agents for postmenopausal osteoporosis.Background
Osteoporosis, the most serious bone remodeling disease,
is defined by low bone mass and a high risk of fractures.
It mainly affects postmenopausal women and elderly
men. Osteoporosis is caused by abnormal bone remodel-
ing (i.e., access of resorption and less formation), result-
ing in an increased risk of hip and vertebral fracture [1].* Correspondence: gxiao@creighton.edu; judahong@sohu.com
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reproduction in any medium, provided the orBone remodeling in healthy bone is an essential process
for maintaining bone quality and repairing damaged
bone that can adapt appropriately to mechanical stimuli.
Osteoporosis is a condition in which loss of bone mass
leads to fragility fractures. Postmenopausal osteoporosis
caused by estrogen deficiency is characterized by a high-
turnover state in bone remodeling; that is, bone resorp-
tion and formation were all maintained at a high level,
but the bone resorption rate was higher than the bone
formation rate in postmenopausal women [2].
The development of bone fragility in postmenopausal
women results from changes in bone remodeling that
leads to alteration of trabecular bone volume and archi-
tecture [3]. In rats, ovariectomy (OVX)-induced boneThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cause of similarities in skeletal responses to estrogen de-
ficiency between rats and humans, the mature OVX rat
is considered a good animal model for studying early
postmenopausal bone loss [4].
Hormone replacement therapy (HRT) is an established
regime for prevention of postmenopausal bone loss [5],
but recent evidence indicates that its long-term use is
accompanied by side effects, such as the increased risk
of breast, ovarian, and endometrial cancer [6]. Thus, al-
ternative therapeutic strategies with proven efficacy and
safety should be developed for the prevention and treat-
ment of osteoporosis.
Chinese herbal medicine has been widely used in clin-
ical practice to treat bone disease for thousands of years
and will undoubtedly continue to be used as a cost-
effective alternative medicine in China. Three Chinese
herbs, Radix Dipsaci (RD), Pyrola Herb (PH), and Cyno-
morium songaricum (CS) have been used to reinforce
the kidney-yang and strengthen bone. Although the
therapeutic effects of these herbs on osteoporosis
induced by estrogen deficiency are yet unknown, recent
study suggests that RD crude extract could increase
bone mass and alter bone histomorphology in rats [7].
The objective of this study was to evaluate the effects of
Radix Dipsaci decoction (RDD), Pyrola Herb decoction
(PHD), and Cynomorium songaricum decoction (CSD)
on postmenopausal osteoporosis.
Methods
Identification and preparation of herb decoctions
Radix Dipsaci (RD) is the dried roots of Dipsacus asper-
oides C. Y. Cheng et T. M. Ai produced in China, and
was collected by the Zhonghong Herbal Drug Co. Ltd.
(Sichuan, China) in March 2007, and identified and
authenticated by an expert herbalist at the Institute of
Chinese Materia Medica, China Academy of Chinese
Medical Sciences (CACMS).
Pyrola Herb (PH) is the dried aerial parts of Pyrola
calliantha H. Andr produced in China, and was col-
lected by the Huanghe Herbal Drug Co. Ltd. (Gansu,
China) in March 2007, and identified and authenticated
by an expert herbalist at the Institute of Chinese Materia
Medica, CACMS.
Cynomorium songaricum (CS) is the dried fleshy stem
of Cynomorium songaricum Rupr produced in China,
and was collected by the Taizhou Herbal Drug Co. Ltd.
(Zhejiang, China) in March 2007, and identified and
authenticated by an expert herbalist at the Institute of
Chinese Materia Medica, CACMS.
After collection, all the dried herbs were stored in a
dry and sealed container at 4°C to protect them from
moisture and moths.Decoctions of RD, PH, and CS were extracted from
the herbs by boiling 300 grams of the dried RD, PH, and
CS in 6 liters of water at 100°C for 2 h. Each decoction
was then concentrated to a final concentration of 1
crude drug gram per milliliter.
Animals and experimental procedures
Sixty-nine virgin Wistar rats (3 months old) in a body
weight range of 250 ± 20.0 grams were obtained from
The Experimental Animal Center of the Academy of
Military Medical Sciences (Beijing, China) and housed in
cages at the experimental animal room at the Institute
of Basic Theory of Traditional Chinese Medicine in
CACMS. These rats were maintained at 22°C with a
12 h light/dark cycle and fed with a standard rodent
chow diet (produced by The Animal Center of The
Fourth Military Medical University, Xi’an, China) con-
taining 0.9% calcium and 0.7% phosphate, with distilled
water available ad libitum.
The acclimatized rats either underwent sham surgery
(a faked operative intervention that omits the step
thought to be therapeutically necessary) (sham, n = 12)
or bilaterally ovariectomized (OVX, n = 57) using the
dorsal approach [8]. Briefly, a surgical procedure on each
of the anesthetized rats was performed with a single lon-
gitudinal skin incision on the dorsal midline at the level
of the kidneys. Both ovaries were ligated and removed.
Rats in the sham group underwent sham surgery, during
which the ovaries were exposed and remained intact.
The OVX rats were randomly divided into five groups:
OVX control group (OVX, n = 12), positive control
group treated with diethylstilbestrol (E2, n = 12), and
three groups treated with RDD (n = 11), PHD (n = 11),
and CSD (n = 11), respectively. Non-surgical rats (n = 12)
were used as normal control (NC). The rats in the E2
group received diethylstilbestrol at a dose of 0.008 mg/
ml (dissolved in distilled water) orally. The rats in the
RDD, PHD, and CSD treatment groups were fed intra-
gastrically with RDD at 5.6 ml per kg body weight a day,
PHD at 5.6 ml per kg body weight a day, and CSD at
5.6 ml per kg body weight a day, respectively. This dose,
about 40-fold lower than LD50 of these herbs (222.84 g/
kg body weight), was optimized in our pre-experimental
studies (data not shown). Rats in the NC, sham, and
OVX control groups were administrated with an equal
volume of distilled water to that in the decoction treat-
ment groups. All the treatments were started four weeks
after the surgery and continued for 12 weeks. The body
weight of each rat was monitored weekly to assess the
effect of the treatments.
On the fifteenth and third days before sacrifice, all the
rats received tetracycline at 30 mg/kg by intraperitoneal
injection. After sacrifice, the success of ovariectomy was
confirmed at necropsy by failure to detect ovarian tissue
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All animals were maintained according to the Guide
for Care and Use of Laboratory Animals, with the ap-
proval of the Institutional Ethics Committee of the
CACMS.Bone histomorphometry
After sacrifice, the tibiae were dissected for histomor-
phometrical analysis. Proximal right tibiae were fixed in
4% paraformaldehyde for 24 h, then dehydrated in an
ethanol gradient of 80%, 90%, and 100% for two days at
each step. Dehydrated samples were defatted in xylene
for two days before embedding in plastic polymer solu-
tion I (100 ml Methyl Methacrylate Monomer, 35 ml
Butyl Methacrylate, 5 ml Methyl Benzoate, and 1.2 ml
Polyglycol 1.2 ml), solution II (solution I, 0.4 gram Dry-
ing Benzoyl Peroxide), and solution III (solution II, 0.8
gram Drying Benzoyl Peroxide) for three days at each
step. Each undecalcified tissue was sliced into two longi-
tudinal sections at 5 μm thickness using microtome.
One section was stained with toluidine blue, and the
other was used for fluorescence morphology observa-
tion. Proximal left tibiae were fixed in 4% paraformalde-
hyde for 24 h, then decalcified in a decalcifying solution
of 10% EDTA (pH7.3) at 4°C for three weeks. After that,
the decalcified samples were dehydrated in 15% sucrose
solution for 10 h. Each sample was sliced into sections
of 5 μm thickness each by freezing microtome. Frozen
sections were fixed in acetone and ready for use for ana-
lysis of immunohistochemistry and in situ hybridization.
Undecalcified tibial slides were used for analysis of
bone remodeling activity. All measurements were per-
formed using the Qwin Image analysis system (Leica
Corporation, Bensheim, Germany). Six bone histomor-
phometric parameters were analyzed, including percent-
age of trabecular bone volume (TBV%), percentage of
trabecular resorption surface (TRS%), percentage of tra-
becular formation surface (TFS%), mineralization rate of
trabecula (MAR), mineralization rate of bone cortex
(mAR), and osteoid mean width (OSW)Methylene blue staining
The undecalcified tibial sections were coated in Methyl
Methacrylate Monomer solution for 2 h, then dehy-
drated in xylene solution for 1 h twice to remove resin.
The samples were then rehydrated in an order of ethanol
gradients, 100%, 90%, 80%, and 0% (in water). The rehy-
drated samples were stained with 1% toluidine blue, then
rinsed with water. After that, the stained slides were
dehydrated in an ethanol gradient of 80%, 90%, and
100%. Dehydrated slides were defatted in xylene, then
sealed for microscopic analysis.Immunohistochemical analysis
Frozen sections were mounted onto glass slides and used
for immunohistochemical analysis. Protein expression
level of RANKL and OPG in tissue sections was esti-
mated using rat antibodies of either anti-RANKL
(1:1000) or anti-OPG (1:1000) (Santa Cruz Biotechnol-
ogy, CA, USA). The sections were rinsed with TBS, then
immersed in 0.3% hydrogen peroxide for 5 min. The
slides were then incubated with specific antibodies for
1 h at 37°C and rinsed with TBS three times for 3 min.
Sections were then incubated with the appropriate
unbiotinylated secondary antibody (Zhongshan Golden-
bridge Biotechnology Co. Ltd, Guangzhou, China) for
30 min at 37°C. Slides were then incubated with a solution
containing DAB (1, 4-dideoxy-1,4-imino-D-arabinitol-
diaminobenzidine; Sigma, USA) for 3 min and rinsed with
running water, then counterstained with Harris hematoxylin
and sealed for microscopic examination. Slides incubated
with nonimmune goat serum, instead of the primary anti-
body, served as negative control.
Image analysis was performed using the Qwin Image
analysis system (Leica Corp, Bensheim, Germany). Five
images from each tibial section of a rat were randomly
captured with 400× magnification. The relative level of
the osteoblasts (OB) and bone marrow stromal cells
(bMSC) in trabecular area was calculated as a percent-
age based on the positive stained area of either OB or
bMSC over the trabecular area in the selected images.
In situ hybridization
After a brief warm-up at room temperature, frozen sec-
tions were immersed in solution of 30% hydrogen dioxide
and methanol for 30 min, then incubated with pepsin
diluted by 3% citric acid at 37°C. After that, the sections
were postfixed in 1% paraformaldehyde for 10 min. Sec-
tions were then incubated with the DIG-labeled antisense
cRNA probes at 38°C-42°C overnight in a humidified
chamber. After multiple washes in 4 × SSC at room
temperature, slides were incubated in a blocking reagent
for 30 min at 37°C, then with a biotinylated anti-digoxin
antibody for 60 min, SABC for 20 min, and the biotiny-
lated peroxydase for 20 min, at 37°C, followed by staining
with DAB (Sigma-Aldrich Corp.). Finally, sections were
covered with glycerol-gelatin and coverslips, and were
ready for microscopic examination. The primer sequences
















All values were expressed as mean ± standard deviations.
All analyses were carried out using SPSS 12.0 (SPSS Inc.,
Chicago, IL, USA). The difference between the groups
regarding the evaluated parameters was tested using the
ANOVA test followed by the Tukey test. The data of all
groups passed the Kolmogorov-Smirnov test of normal-
ity. All groups were carried out in triplicate and signifi-
cance was accepted when P ≤ 0.05.Results
Effects of RDD, PHD, and CSD on bone formation
To investigate the effects of the herbal medicines on
overall bone formation, we analyzed trabecular bone for-
mation in the undecalcified tibial sections from tibiae of
OVX rats treated with RDD, PHD, and CSD using
methylene blue staining (Figure 1). Trabecular bone for-
mation was estimated by numbers of stained trabeculae
in the undecalcified section. Figure 1 shows that tra-
becular bone formation was reduced significantly in the
ovariectomized rats compared to rats in normal control
and sham groups, while this effect was remarkably
reversed by E2 treatment. Numbers of trabeculae in the
stained tibial section were significantly increased inFigure 1 Effects of RDD, PHD, and CSD on bone formation. Trabecular
the details in the Methods section of the text.OVX rats treated with RSD and PHD, but not with CSD
(Figure 1), compared to that in OVX control.
Effects of RDD, PHD, and CSD on bone histomorphometry
Bone remodeling is a lifelong process in which two
counter-balanced processes (bone resorption and bone
formation) are involved. Bone remodeling activity can be
monitored by measuring histomorphometric indices and
bone remodeling markers. To further estimate the
effects of RDD, PHD, and CSD on bone remodeling ac-
tivity, we analyzed six bone histomorphometric para-
meters, including TBV%, TRS%, TFS%, MAR, mAR, and
OSW in OVX rats treated with the Chinese herbs and
E2 using histomorphometry (Table 1). TBV% was signifi-
cantly reduced (p < 0.01) in rats with estrogen deficiency
induced by ovariectomy. Yet, TRS%, TFS%, MAR, mAR
(p < 0.01) and OSW (p < 0.05) were increased signifi-
cantly in these OVX rats.
E2 treatment significantly reversed the effects of ovari-
ectomy on histomorphometric indices by decreasing
TBV% and increasing TRS%, TFS%, MAR, mAR, and
OSW in OVX rats. Either RDD or PHD treatment
showed a similar effect to E2 treatment on bone histo-
morphometric indices. However, CSD treatment had no
significant effect on the six indices (p > 0.05) (Table 1).
Effects of RDD, PHD, and CSD on protein expression of
OPG and RANKL
To monitor bone remodeling activity in OVX rats treated
with the herbs, we analyzed biomarker expression of bone
remodeling using immunohistochemistry (Figures 2A, B).
OPG expression was decreased significantly in either OB
or bMSC of tibia from OVX rats compared to the shambone formation was visualized by using methylene blue staining. See
Table 1 Effects of RDD, PHD, or CSD on bone histomorphometry in rats treated for 12 weeks
Group n TBV% TRS% TFS% MAR(μm/d) mAR(μm/d) OSW(μm)
Sham 12 27.18 ± 8.78 3.40 ± 1.54 7.40 ± 2.41 1.38 ± 0.16 2.28 ± 0.47 6.20 ± 1.29
OVX 12 8.945 ± 3.04a 9.31 ± 2.22a 14.54 ± 3.31a 1.86 ± 0.23a 3.03 ± 0.60a 7.77 ± 1.64b
E2 12 23.61 ± 4.71c 3.28 ± 1.31c 7.72 ± 2.66c 1.32 ± 0.22c 2.15 ± 0.70c 6.37 ± 1.42d
RDD 11 12.43 ± 2.96d 5.71 ± 1.72c 11.26 ± 2.97d 1.59 ± 0.25d 2.77 ± 0.42 7.35 ± 1.14
PHD 11 18.58 ± 5.53c 4.63 ± 1.42c 12.44 ± 3.26 1.95 ± 0.36 2.84 ± 0.71 7.86 ± 1.79
CSD 11 11.95 ± 3.87 8.60 ± 2.23 15.20 ± 4.11 1.68 ± 0.35 2.81 ± 0.49 7.80 ± 1.46
Values are mean ± S.D.
a p < 0.01 different from sham control group.
b p < 0.05 different from sham control group.
c p < 0.01 different from the OVX control group (one-way ANOVA).
d p < 0.05 different from the OVX control group (one-way ANOVA).
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caused overexpression of OPG in OB and bMSC of tibia
from OVX rats compared to that from the OVX control
group (p < 0.05, Figure 2A); however, treatment with ei-
ther RDD or CSD had no significant effect on OPG ex-
pression (p > 0.05).
We also analyzed RANKL expression in OB or bMSC
of tibia from OVX rats treated with RDD, PHD, CSD, or
E2 for 12 weeks of treatment using immunohistochem-
istry. Ovariectomy caused a significant increase in
RANKL expression in OB or bMSC of tibia compared
to that from the sham group (p < 0.01, Figure 2B).
Expression of RANKL in OB or bMSC of tibia from
OVX rats decreased significantly upon treatment with
E2, RDD, or PHD (p < 0.01, p < 0.05, and p < 0.05, re-
spectively, Figure 2B), but not with CSD (p > 0.05).
The ratio of RANKL/OPG in OB and bMSC of tibia
from OVX rats was increased significantly compared to
that in the normal control or sham groups (p < 0.01,
Figure 2C). Compared to OVX alone, the ratio of RANKL/
OPG decreased remarkably in OB and bMSC of tibia from
OVX rats treated with either E2 (p < 0.01) or PHD treat-
ment (p < 0.05); however, no significant changes in the
ratio of RANKL/OPG were observed in OB and bMSC of
tibia from OVX rats treated either with RDD or CSD
(Figure 2C).Effects of RDD, PHD, and CSD on mRNA expression of
RANKL and OPG
To determine whether RDD, PHD, and CSD caused
mRNA changes in RANKL and OPG in OB and bMSC
of tibia from OVX rats, we examined mRNA levels of
RANKL and OPG using in situ hybridization. OVX
resulted in a significant decrease in expression of OPG
mRNA in either OB or bMSC of tibia from OVX rats
compared to the sham group (Figure 3A). The level of
OPG mRNA in both OB and bMSC of tibia from OVX
rats was induced significantly by treatment with either
E2 or PHD, but no significant changes of OPG mRNAwere observed with treatment with either RDD or CSD
compared to that in the OVX control group (Figure 3A).
Expression of RANKL mRNA in OB or bMSC of tibia
from the OVX rats was increased significantly compared
to either the NC or sham groups (Figure 3B). Expression
of RANKL mRNA was decreased remarkably in OB and
bMSC of tibia from OVX rats treated with either E2 or
PHD (Figure 3B), but no significant difference in
RANKL mRNA was observed in OB and bMSC of tibia
from OVX rats treated with either RDD or CSD.
The ratio of RANKL/OPG mRNA in OB and bMSC
of tibia from OVX rats was increased significantly
compared to that in normal control or sham groups
(p < 0.01, Figure 3C). Compared to OVX alone, the
ratio of RANKL/OPG mRNA decreased remarkably in
OB and bMSC of tibia from OVX rats treated with
either E2 (p < 0.01) or PHD (p < 0.05); however, no sig-
nificant changes in the ratio of RANKL/OPG were
observed in OB and bMSC of tibia from OVX rats
treated with either RDD or CSD (Figure 3C).Discussion
RD, PH, CS, and other kidney-tonifying traditional
Chinese medicines (TCM) have been widely used for
thousands of years to treat bone diseases in China. The
theory of Chinese medicine is to restore balance at all ef-
fective levels. Although these herbal medicines are con-
sidered a cost-effective alternative by Chinese people,
lack of knowledge about their mechanisms limited their
application as an alternative therapeutic regime to treat
osteoporosis in most Western countries.
Previous studies showed that ovariectomy induced
bone loss, resulting in an increased risk of osteoporosis.
Our results from this study confirm this notion, indicat-
ing that the mature OVX rat is a good animal model of
osteoporosis for evaluating the efficacy of herbal medi-
cines as therapies for early postmenopausal osteoporosis.
Recently, several studies of herbal medicines have been
performed to evaluate their antiosteoporotic effects,
Figure 2 Effects of RDD, PHD, and CSD on protein expression of OPG and RANKL. A) Immunohistochemical stain of OPG; B)
Immunohistochemical stain of RANKL; C) Ratio of RANKL/OPG protein expression, RANKL and OPG protein expression data were obtained from
panels A and B of this figure, see details in the Methods section of the text, (a, p < 0.01, b, p < 0.05). All the experiments were repeated three
times.
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Figure 3 Effects of RDD, PHD, and CSD on expression of OPG and RANKL mRNA. A) In situ hybridization of OPG in OB and MSC; B) In situ
hybridization of RANKL in OB and bMSC; C) Ratio of RANKL/OPG mRNA expression, RANKL and OPG mRNA expression data were obtained from
panels A and C of this figure, see details in the Methods section of the text, (a, p < 0.01, b, p < 0.05). All the experiments were repeated three
times.
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useful alternative medicines for treatment of osteopor-
osis [9,10]. Shirwaikar et al. used ethanol extract of Cis-
sus quadrangularis (CQ) to treat an ovariectomized rat
model of osteoporosis, and found that CQ ethanol ex-
tract of the plant had a definite anti-osteoporotic effect
[9]. Chae’s group studied the anti-osteoporotic effect of
the herbal medicine Salvia miltiorrhiza (SM), showing
that SM ameliorated the decrease in BMD and trabecu-
lar bone mass of OVX-induced osteoporosis rats and
decreased the serum level of osteoclast markers and oxi-
dative stress markers. Based on the property of anti-
oxidative stress, SM may be developed as a promising
natural therapy for osteoporosis [10]. So far, there has
been no report about the anti-osteoporotic effects of
Radix Dipsaci (RDD), Pyrola Herb (PHD) and Cynomor-
ium songaricum decoctions (CSD), as used in this study,
in which the effects of these medicines on an ovariecto-
mized rat model of osteoporosis were evaluated.
Although E2 is no longer used in clinical practice due
to its side effects, use of E2 as control in this study is to
help us understand the mechanism of action of the herb
medicines in OVX rats. As expected, OVX rats treated
with E2 for 12 weeks ameliorated the loss of bone mass,
which was reflected by the increased TBV% and the
decreased levels of TRS%, TFS%, MAR, OSW, and mAR.
The effect of either RDD or PHD on TBV% and TRS%
was similar to that of E2; however, the effect of either
RDD or PHD on mAR and OSW of tibia from OVX rats
was not significant, suggesting that either RDD or PHD
may have a limited effect on bone cortex mineralization
and osteoid formation. In addition, OVX rats treated
with PHD did not show significant decreases in TFS%
and MAR, suggesting that a possible anti-osteoporotic
mechanism of PHD may be through inhibition of bone
resorption.
It is well known that the RANKL/RANK/OPG signal-
ing pathway plays a key role in the regulation of bone
remodeling [11]. RANK is a receptor located on surface
osteoclasts (precursor and mature). Ligands of RANK
are OPG and RANKL, synthesized and secreted primar-
ily by osteoblasts and bone marrow stromal cells [12].
Activation of RANK by RANKL initiates a RANK/
RANKL/OPG signaling cascade, resulting in osteoclast
differentiation and increased bone resorption. OPG,
which acts as a decoy receptor for RANKL, blocks this
interaction. The importance of this pathway in bone me-
tabolism is demonstrated by the facts that pharmaco-
logic blockage of RANKL is an effective treatment for
osteoporosis [13], an inherited deficiency of RANK or
RANKL causes osteopetrosis, and loss-of-function osteo-
protegerin mutations cause juvenile Paget’s disease
[14,15]. Different from previous studies [9,10], this
study’s purpose was to answer how herbal medicinesregulate the major bone remodeling pathway. We found
that OVX could downregulate protein and mRNA ex-
pression of OPG and upregulate protein and mRNA
expression of RANKL in OB or bMSC compared with
the sham group, while E2 or PHD treatment could re-
verse this condition significantly. RDD could only sig-
nificantly downregulate protein and mRNA expression
of RANKL and had no significant effect on protein and
mRNA expression of OPG. The results indicated that
one of mechanisms at work in the inhibition of osteope-
nia by E2, PHD, and RDD lay in their modulation of the
effects on OPG and RANKL.
Conclusion
By comparison, this study demonstrated for the first
time the potential protective effects of RDD and PHD
on OVX-induced osteoporosis in rats. RDD and PHD
could prevent the OVX-induced loss of bone mass; their
preventive effects depended on modulating protein and
mRNA expression of OPG and (or) RANKL in OB and
bMSC. Our study provides evidence that Radix Dipsaci
and Pyrola Herb extract have the potential to be used
for the treatment of postmenopausal osteoporosis.
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